Uroweb - European Association of Urology (EAU)

Raising the level
of urological care
About the EAU ›
EAU Guidelines: the best current evidence
for clinical practice
Read more ›
The EAU learning
library for urologists
Read more ›
Join the biggest international community
for urology
Read more ›
European Association of Urology Nurses (EAUN)
Visit Website ›

Whether you are a resident, a young urologist or an experienced specialist, your career can benefit from an EAU Membership. The EAU supports you throughout your career with programmes for continuing medical education and certification. For young and upcoming EAU members we offer several educational programmes, scholarships and clinical visits. Members have advanced access to the Resource Centre.

For any successful clinician, having the most up-to-date evidence-based recommendations on hand is crucial for the successful treatment of your patients. The EAU Guidelines are unparalleled in that regard, used all across the world. They are comprehensively updated on an annual basis and freely accessible for all members.

Urologists are bound by national and, increasingly, international laws that govern treatment options and patient care. The EAU brings together the voices of medical professionals, researchers, innovators and patients on a European platform to keep urological topics on the agendas of the authorities.

The EAU offers a wide range of events and courses to interact with the best specialists in the field of urology. The Annual EAU Congress is the largest urology-related event in the world where you can network with like-minded professionals.

Our journal, European Urology, has been a prestigious urological forum for over 35 years, and is currently read by more than 20,000 urologists. It is one of the most widely-cited medical journals in the world and, with an impact factor of 17.298, leading in its field. Members have free access to full-text articles. Members also have access to European Urology Focus and European Urology Oncology.

Additionally, the independent EAU Research Foundation conducts clinical trials to add valuable data to the pool of scientific knowledge in Europe. Only as a member you are eligible to apply for grants and funding.

About European Association of Urology

For almost 40 years the EAU has addressed the most pressing issues of urological care in Europe, through its scientific and educational initiatives, as well as its publications. Become a member and get access to the benefits:

Member benefits

Latest News

EMUC19: ARAMIS trial likely to change Guidelines recommendations

The third day of the EMUC meeting (and the second day of the main scientific programme) opened with a two-hour session on new trials. Like all sessions at EMUC19, it was chaired by a multidisciplinary group, in this case...

EMUC19: HoT courses highlight MRI reading and fusion biopsy

Two Hands-on Training (HoT) courses organised by the European School of Urology (ESU) and the EAU Section of Urological Imaging (ESUI) simultaneously commenced on day 2 of the 11th European Multidisciplinary Congress on Urological Cancers (EMUC19). The ESU/ESUI Hands-on Training...

EMUC19: A multidisciplinary look at early detection of prostate cancer

Using the fortieth anniversary of the discovery of PSA as a starting point, EMUC19 began with a session on early prostate cancer detection. The session immediately demonstrated the multidisciplinary nature of the EMUC scientific programme, drawing on the expertise...

ESUI19 delivers latest MRI essentials

The 8th Meeting of the EAU Section of Urological Imaging (ESUI19) kick-started with the session “The MRI corner” which was moderated by ESUI Chairman Prof. Georg Salomon (DE), Prof. Dr. Tillmann Loch (DE), and Prof. Arnauld Villers (FR). In...

ESUI19: PSMA PET updates on rationale use, RGS and tracers

New developments on radioguided surgery, tracers, and rationale use of the prostate-specific membrane antigen positron emission tomography (PSMA PET) were explored today during the session “The PSMA PET Corner” of the 8th Meeting of the EAU Section of Urological...

EAU: Focused strategy to encourage timely detection PCa

With a remarkable upturn in prostate cancer mortality, the time has come to encourage earlier detection says EAU Adjunct-Secretary General Prof. Hendrik Van Poppel (BE). “For years, prostate cancer screening was synonymous with overdiagnosis and overtreatment. However, with modern...

Upcoming Events

17th Meeting of the European Section of Oncological Urology (ESOU20)

35th Annual EAU Congress Amsterdam (EAU20)

21st EAUN Meeting, Amsterdam (EAUN20)

Latest Videos

EAU19: Focus on Kidney: CARMENA and Renal Cell Carcinoma – EAU TV

Moderator of Plenary session 4 Renal Cell Carcinoma (RCC) Prof. Markus Kuczyk talked about if CARMENA trial changes everything.
EAU19: Discussing with Axel Merseburger about the primary results from the SAUL study – EAU TV

Prof. Jens Bedke (DE) and Prof. Maria José Ribal discussed the primary results from SAUL study with Prof. Axel Merseburger.
EAU19: Insights from the ESO Prostate Observatory – EAU TV

Prof. van Moorselaar (NL) and Mr. Dowling (IE) gave insights of what urologists and patients can expect in Prostate Cancer treatment over the next year during the ESO Prostate Observatory at the 34th Annual EAU Congress in Barcelona.
EAU19: Urology Nightmares – ‘Forgotten’ ureteral stents: Whose responsibility? – EAU TV

EAU19 had an animated start on Saturday with Plenary Session 2; a ‘nightmare session’ on stones. Mr. Bertie Leigh (GB), veteran consultant solicitor, challenged some of Europe’s best stone surgeons on the troubling cases they presented.
EAU19 Daily Debate: Imaging in Urology – EAU TV

Dr. Sanchez-Salas (FR) and Prof. Murphy (AU) discussed recent changes in the diagnostic pathway of clinically localized prostate cancer. In particular, the role of novel imaging techniques and biopsy approaches such as multiparametric MRI and MRI-targeted biopsy.
EAU19: EAU Policy Paper on PSA screening – EAU TV

At the 34th Annual EAU Congress in Barcelona Prof. Van Poppel (BE) talked about the policy papers addressing the need to reconsider structured population-based PSA screening for prostate cancer.